BSF shares jump 56% on US joint venture for lab-grown leather

Shares in BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) soared 56.5% to 1.33p on Monday after the tissue engineering company agreed outline terms for a joint venture to sell its lab-grown leather into the American luxury market. The London-listed group has signed non-binding heads of terms with IMPOSTER, a US brand operator, to form a 50/50 venture. BSF will put in no cash at all. Its contribution is technology licensing and access to material supply, with IMPOSTER expected to provide operational funding of between $500,000 and $1 million drawn from a planned $3.5 million growth capital raise. Full commercial exclusivity for the venture only switches on once that money arrives. BSF makes T-Rex Leather, a material grown from cells in a laboratory rather than taken from animal hides, through its Lab-Grown Leather subsidiary. The venture will be confined to small luxury items including bag charms, keyrings, desk accessories and equestrian goods, plus a limited run of bespoke handbags and wallets. That narrow scope is deliberate. BSF keeps all intellectual property and every commercial right in the higher-volume categories that matter most, among them mainline footwear, apparel, automotive interiors and mass-market handbags. The company said it wanted to preserve freedom to strike its own deals with global luxury houses. An immediate marketing phase begins this month, with showcase products appearing at the Hampton Classic Horse Show, then New York Fashion Week in September and the Humane World Gala in November. BSF is targeting three revenue streams: a gross margin of 25% to 35% on raw material transfers, a royalty of 3% to 7% on net sales, and half of any venture profits.